Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 2842143, 7 pages
http://dx.doi.org/10.1155/2016/2842143
Research Article

Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus

1Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
2Department of Neurology, Chinese Navy General Hospital, Beijing 100048, China
3Department of Geriatric Gastroenterology, Chinese People’s Liberation Army General Hospital, Beijing 100853, China
4Department of Hematology and Rheumatology, Hanzhong 3201 Hospital, Medicine School of Xi’an Jiaotong University, Hanzhong 723000, China

Received 18 December 2015; Accepted 23 February 2016

Academic Editor: Amedeo Amedei

Copyright © 2016 Jinlin Miao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Tsokos, “Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 365, no. 22, pp. 2110–2121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. C. Mok and C. S. Lau, “Pathogenesis of systemic lupus erythematosus,” Journal of Clinical Pathology, vol. 56, no. 7, pp. 481–490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Bessant, A. Hingorani, L. Patel, A. MacGregor, D. A. Isenberg, and A. Rahman, “Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus,” Rheumatology, vol. 43, no. 7, pp. 924–929, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. E. Hak, E. W. Karlson, D. Feskanich, M. J. Stampfer, and K. H. Costenbader, “Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study,” Arthritis Care and Research, vol. 61, no. 10, pp. 1396–1402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Gorman and D. Isenberg, “Atherosclerosis and lupus,” Rheumatology, vol. 43, no. 8, pp. 943–945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Esdaile, M. Abrahamowicz, T. Grodzicky et al., “Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 44, no. 10, pp. 2331–2337, 2001. View at Google Scholar · View at Scopus
  7. J. Hur, H.-M. Yang, C.-H. Yoon et al., “Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies,” Circulation, vol. 116, no. 15, pp. 1671–1682, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. R. P. W. Rouhl, A. E. C. S. Mertens, R. J. van Oostenbrugge et al., “Angiogenic T-cells and putative endothelial progenitor cells in hypertension-related cerebral small vessel disease,” Stroke, vol. 43, no. 1, pp. 256–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Rodríguez-Carrio, M. Alperi-López, P. López, S. Alonso-Castro, F. J. Ballina-García, and A. Suárez, “Angiogenic T cells are decreased in rheumatoid arthritis patients,” Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 921–927, 2015. View at Publisher · View at Google Scholar
  11. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  12. P. Y. Lee, Y. Li, H. B. Richards et al., “Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 56, no. 11, pp. 3759–3769, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Robak, A. Wóniacka, A. Sysa-Jedrzejowska, H. Stepień, and T. Robak, “Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity,” European Cytokine Network, vol. 12, no. 3, pp. 445–452, 2001. View at Google Scholar · View at Scopus
  14. E. Robak, A. Sysa-Jedrzejewska, and T. Robak, “Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus,” Mediators of Inflammation, vol. 12, no. 5, pp. 293–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Lopez, J. Rodriguez-Carrio, A. Martinez-Zapico, L. Caminal-Montero, and A. Suarez, “Senescent profile of angiogenic T cells from systemic lupus erythematosus patients,” Journal of Leukocyte Biology, 2015. View at Publisher · View at Google Scholar
  16. D. Su, R. Liu, X. Li, and L. Sun, “Possible novel biomarkers of organ involvement in systemic lupus erythematosus,” Clinical Rheumatology, vol. 33, no. 8, pp. 1025–1031, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Magro and A. N. Crowson, “The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus,” The American Journal of Dermatopathology, vol. 21, no. 2, pp. 129–137, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. López-Longo, D. Oliver-Miñarro, I. de La Torre et al., “Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis,” Arthritis Care and Research, vol. 61, no. 4, pp. 419–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. J. Grainger and H. W. L. Bethell, “High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis,” Annals of the Rheumatic Diseases, vol. 61, no. 2, pp. 110–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. K. P. Liang, H. M. Kremers, C. S. Crowson et al., “Autoantibodies and the risk of cardiovascular events,” Journal of Rheumatology, vol. 36, no. 11, pp. 2462–2469, 2009. View at Publisher · View at Google Scholar · View at Scopus